Filing Details
- Accession Number:
- 0000899243-19-028606
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-05 18:08:44
- Reporting Period:
- 2019-12-03
- Accepted Time:
- 2019-12-05 18:08:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1631574 | Wave Life Sciences Ltd. | WVE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657675 | Chandra Vargeese | C/O Wave Life Sciences Ltd., 733 Concord Ave. Cambridge MA 02138 | Senior Vp, Drug Discovery | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-12-03 | 6,000 | $2.48 | 46,245 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2019-12-03 | 6,000 | $35.00 | 40,245 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Share Option (right to buy) | Disposition | 2019-12-03 | 6,000 | $0.00 | 6,000 | $2.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 143,542 | 2025-03-10 | No | 4 | M | Direct |
Footnotes
- The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019.
- The incentive share option initially represented a right to purchase a total of 158,042 ordinary shares, 25% of which became exercisable on August 1, 2015, and the remaining shares vest in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
